Sanjiv Sam Gambhir, MD, PhD

Clinical Trials

• Recruiting 3D Dynamic Contrast-Enhanced Ultrasound Imaging in Predicting Treatment Response in Patients With Liver Metastases From Colon Cancer
• Recruiting Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
• Not Recruiting F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
• Not Recruiting Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
• Recruiting 18F FPPRGD2 Positron Emission Tomography/Computed Tomography in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
• Recruiting PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases
• Not Recruiting Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
• Recruiting Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy
• Not Recruiting Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer
• Not Recruiting Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System
• Not Recruiting Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study
• Not Recruiting Correlation of PET-CT Studies With Serum Protein Analysis
• Not Recruiting Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT
• Not Recruiting Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study
• Recruiting FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
• Not Recruiting Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT